Tuesday 1st August 2017 – SYNLAB, the leading provider of medical diagnostic services in Europe, has today announced the acquisition of Lextox Drug and Alcohol Testing based in Cardiff.
Lextox is an ISO 17025 UKAS accredited laboratory specialising in hair drug and alcohol testing. Lextox offers a broad range of services and is the trusted choice for over 12,000 solicitors and local authorities across the UK. In addition to hair drug and alcohol testing, Lextox experts provide Analysis and Expert Reports for courts, solicitors and local authorities involved in family law cases and child care proceedings.
SYNLAB was attracted to the Lextox business due to the dynamism of the company and the management team, its high-quality service provision and strong value-added strategy, as well as its complementary offering to that of Abergavenny based SYNLAB Laboratory Services.
The acquisition further extends SYNLAB’s repertoire of drug and alcohol testing services in the UK. This offers growth opportunities for both companies, as well as deepening both the company’s expertise and customer offerings in existing and new markets.
The SYNLAB Group is the leading laboratory services provider in Europe. SYNLAB offers a full range of innovative and reliable medical diagnostics for patients, practising doctors, clinics and the pharmaceutical industry. Providing the leading level of service within the industry, SYNLAB is the partner of choice for healthcare professionals. SYNLAB’s services also encompass veterinary and environmental laboratory analysis.
SYNLAB operates in more than 30 countries across four continents and holds leading positions in most markets. Over 17,000 employees contribute every day to the Group’s success across different geographies. SYNLAB carries out about 450 million laboratory tests per year, achieving sales revenue of circa €1.6 billion.
For more information on the SYNLAB Group, please visit www.synlab.com.